Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Variance of pain prevalence and associated severity during the transfusion cycle of adult thalassaemia patients.

Green ST, Martin MB, Haines D, Carson S, Coates T, Oliveros O, Gerstenberger E, Trachtenberg F, Kwiatkowski JL; Thalassaemia Clinical Research Network.

Br J Haematol. 2014 Sep;166(5):797-800. doi: 10.1111/bjh.12903. Epub 2014 May 8. No abstract available.

2.

Pain in thalassaemia: the effects of age on pain frequency and severity.

Haines D, Martin M, Carson S, Oliveros O, Green S, Coates T, Eile J, Schilling L, Dinu B, Mendoza T, Gerstenberger E, Trachtenberg F, Vichinsky E; Thalassemia Clinical Research Network.

Br J Haematol. 2013 Mar;160(5):680-7. doi: 10.1111/bjh.12177. Epub 2012 Dec 30.

PMID:
23278768
3.

Use of leukocyte poor blood: I. Effect on frequency and severity of non hemolytic transfusion reactions.

Reverberi R, Moretti M, Ferrari L, Menini C.

Riv Emoter Immunoematol. 1983;30(1):39-49. No abstract available.

PMID:
6635479
4.

Succesful treatment of chronic hepatitis C virus infection with daclatasvir and asunaprevir in a transfusion dependent thalassaemia patient.

Köklü H, Köklü S, Ozturk O, Aksoy EK, Tseveldorj N.

Acta Gastroenterol Belg. 2016 Sep-Dec;79(4):501-502. No abstract available.

PMID:
28209112
5.

Endocrine complications in transfusion dependent thalassaemia in Penang Hospital.

Ong CK, Lim SL, Tan WC, Ong EE, Goh AS.

Med J Malaysia. 2008 Jun;63(2):109-12.

6.

Renal dysfunction in patients with thalassaemia.

Quinn CT, Johnson VL, Kim HY, Trachtenberg F, Vogiatzi MG, Kwiatkowski JL, Neufeld EJ, Fung E, Oliveri N, Kirby M, Giardina PJ; Thalassemia Clinical Research Network.

Br J Haematol. 2011 Apr;153(1):111-7. doi: 10.1111/j.1365-2141.2010.08477.x. Epub 2011 Feb 21.

7.

Serum immunoreactive erythropoietin level: a new parameter for monitoring transfusion management of thalassaemia.

André M, Bergmann P, Ferster A, Toppet M, Fondu P.

Nouv Rev Fr Hematol. 1991;33(4):299-302.

PMID:
1780235
8.

Problems related to treatment of beta-thalassaemia major.

Economidou J.

Paediatrician. 1982;11(3-4):157-77. Review.

PMID:
7043374
9.

A prospective trial of young red cells in 48 patients with transfusion-dependent thalassaemia.

Marcus RE, Wonke B, Bantock HM, Thomas MJ, Parry ES, Taite H, Huehns ER.

Br J Haematol. 1985 May;60(1):153-9.

PMID:
4005175
10.

Risk of HIV infection in polytransfused thalassaemia patients.

Lefrere JJ, Girot R.

Lancet. 1989 Sep 30;2(8666):813. No abstract available.

PMID:
2571059
11.

Craniofacial deformities in transfusion-dependent thalassemia patients in Malaysia: prevalence and effect of treatment.

Toman HA, Hassan R, Hassan R, Nasir A.

Southeast Asian J Trop Med Public Health. 2011 Sep;42(5):1233-40.

PMID:
22299450
12.

Evaluation of the supertransfusion regimen in homozygous beta-thalassaemia children.

Masera G, Terzoli S, Avanzini A, Fontanelli G, Mauri RA, Piacentini G, Ferrari M.

Br J Haematol. 1982 Sep;52(1):111-3.

PMID:
7115620
13.

High frequency of autoimmunization among transfusion-dependent Tunisian thalassaemia patients.

Guirat-Dhouib N, Mezri M, Hmida H, Mellouli F, Kaabi H, Ouderni M, Zouari B, Hmida S, Bejaoui M.

Transfus Apher Sci. 2011 Oct;45(2):199-202. doi: 10.1016/j.transci.2011.08.003. Epub 2011 Sep 1.

PMID:
21889408
14.

SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan.

Chiou SS, Huang JF, Chang TT, Hsieh MY, Dai CY, Yu ML, Chang WY, Chuang WL.

Digestion. 2006;74(3-4):208-14. Epub 2007 Mar 6.

PMID:
17341855
15.

Post-transfusion-transmitted hepatitis C virus infection: a study on thalassemia and hemodialysis patients in southeastern Iran.

Hassanshahi G, Arababadi MK, Assar S, Hakimi H, Karimabad MN, Abedinzadeh M, Rafatpanah H, Derakhshan R.

Arch Virol. 2011 Jul;156(7):1111-5. doi: 10.1007/s00705-011-0950-y. Epub 2011 Feb 22.

PMID:
21340738
16.

Unexpected prevalence of hyperprolactinaemia associated with microprolactinoma and empty sella in a cohort of adult patients with non-transfusion-dependent thalassaemia: a prospective study.

Ricchi P, Ammirabile M, Spasiano A, Costantini S, Vitale M, Di Matola T, Cinque P, Filosa A, Serino D.

Br J Haematol. 2014 Mar;164(5):743-5. doi: 10.1111/bjh.12668. Epub 2013 Nov 20. No abstract available.

PMID:
24251449
17.

Dr. P. C. Sen Memorial Award Paper. A study of HIV infection in thalassaemia patients of rural Bengal.

Sur D, Chakraborty AK, Mukhopadhyay SP.

Indian J Public Health. 1998 Jul-Sep;42(3):81-7.

PMID:
10389518
18.

Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.

Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK.

Indian J Public Health. 2006 Jan-Mar;50(1):43-4.

PMID:
17193761
19.

Marseillevirus prevalence in multitransfused patients suggests blood transmission.

Popgeorgiev N, Colson P, Thuret I, Chiarioni J, Gallian P, Raoult D, Desnues C.

J Clin Virol. 2013 Dec;58(4):722-5. doi: 10.1016/j.jcv.2013.10.001. Epub 2013 Oct 15.

PMID:
24183312
20.

Study of mechanisms of post-transfusion hypertension in thalassaemic patients.

Thirawarapan SS, Snongchart N, Fucharoen S, Tanphaichitr VS, Dhorranintra B.

Southeast Asian J Trop Med Public Health. 1989 Sep;20(3):471-8.

PMID:
2699089

Supplemental Content

Support Center